Heart damage plagues Covid-19 survivors a year after infection, study shows

They found non-hospitalised Covid patients had a 39% increased risk of developing heart failure and a 2.2-fold increased risk of a potentially deadly blood clot in the following year

cardiovascular
Researchers are still trying to unravel the causes of heart damage in Covid patients
Jason Gale | Bloomberg
3 min read Last Updated : Oct 08 2021 | 8:50 AM IST
Heart damage from Covid-19 extends well beyond the disease’s initial stages, according to a study that found even people who were never sick enough to need hospitalization are in danger of developing heart failure and deadly blood clots a year later.
 
Heart disease and stroke are already the leading causes of death worldwide. The increased likelihood of lethal heart complications in Covid survivors -- who number in the hundreds of millions globally -- will add to its devastation, according to the study, which is under consideration for publication by a Nature journal.

“The aftereffects of Covid-19 are substantial,” said Ziyad Al-Aly, director of the clinical epidemiology center at the Veterans Affairs St. Louis Health Care System in Missouri, who led the research. “Governments and health systems must wake up to the reality that Covid will cast a tall shadow in the form of long Covid, and has devastating consequences. I am concerned that we are not taking this seriously enough.” 

The chances of a heart attack, stroke, or other major cardiovascular event in the first 12 months of Covid recovery increase with the severity of the initial illness, the researchers found. They compared the risks of heart complications in 151,195 veterans who survived Covid to the risk in more than 3.6 million of their peers who didn’t contract the pandemic disease. 

The data were collected from the largest integrated health-care system in the U.S. Most of its users are white and male, which may limit how generalizable the study’s findings are to other groups, the authors said.

They found non-hospitalized Covid patients had a 39% increased risk of developing heart failure and a 2.2-fold increased risk of a potentially deadly blood clot, known as a pulmonary embolism, in the following year, compared with someone who didn’t develop the disease. That works out to an extra 5.8 cases of heart-failure and 2.8 cases of pulmonary embolism for every 1,000 Covid patients who were never hospitalized.

Intensive Care
 
Being hospitalized for Covid is associated with a 5.8-fold increased risk of cardiac arrest and almost a 14-fold greater chance of myocarditis, or inflammation of the heart muscle, the study found. Covid patients who needed intensive care are at significantly greater risk, with almost one in seven suffering a major adverse cardiac event that they wouldn’t have otherwise had within a year. 

Increased risks of cardiovascular complications for Covid survivors over 12 months compared with people not diagnosed with the pandemic disease are listed below: 

  Non-hospitalized Hospitalized
Needed Intensive Care
Cardiac arrest negligible 482%
2,774%
Stroke 24% 177%
310%
Heart Faliure  39% 270%
522%
Pulmonary embolism 119% 855%
2,426%
Myocarditis 277% 1,264%
3,940%


Researchers are still trying to unravel the causes of heart damage in Covid patients. Possible mechanisms include lingering damage from direct viral invasion of heart-muscle cells and the cells that line blood vessels, blood clots and aberrant and persistent inflammation, the authors said.

The findings from natural disasters and previous pandemics suggest indirect effects of Covid-19, including social isolation, financial distress, changes in dietary habits and physical activity, as well as trauma and grief, may also influence the risks for cardiovascular disease, they said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusHeart diseasesHeart Failure

Next Story